Valuation: InterCure Ltd.

Market Cap 15Cr 4.82TCr 14Cr 13Cr 11Cr 21Cr 1.41TCr 22Cr 150.52Cr 60Cr 752.95Cr 56Cr 55Cr 2.39TCr P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 29Cr 9.22TCr 26Cr 24Cr 22Cr 41Cr 2.7TCr 42Cr 287.8Cr 114.12Cr 1.44TCr 107.26Cr 104.99Cr 4.57TCr EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
65.11%
Yield 2024 *
-
Yield 2025 -
1 day-3.17%
1 week+12.32%
Current month-10.74%
1 month-18.64%
3 months-14.16%
6 months-1.49%
Current year-24.47%
1 week 1,088
Extreme 1088
1,310
1 month 1,001
Extreme 1001
1,491
Current year 1,001
Extreme 1001
1,862
1 year 1,001
Extreme 1001
2,371.5
3 years 1,001
Extreme 1001
6,730
5 years 1,001
Extreme 1001
12,685
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 67 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Other

Chief Financial Officer

5,39,947 0.9874%
18/03/26 Other

Director

19,046 0.0348%
18/03/26 Other

Chief Executive Officer

1,72,85,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
-3.17%+12.32%-44.35%-46.93% 4.65Cr
-0.49%+6.56%+14.83%+29.25% 11TCr
-0.32%+0.82%+5.59%+107.01% 10TCr
-1.19%+2.71%+56.20%+502.40% 4.63TCr
+1.26%+2.17%+10.06%+99.63% 3.33TCr
-0.49%+1.07%+38.81%+76.49% 3.01TCr
-0.02%+1.55%+38.86%+91.66% 2.86TCr
-0.29%+0.95%+48.27%+387.69% 2.28TCr
-0.33%-1.26%-17.45%-19.70% 1.98TCr
+0.38%+2.84%-2.93%+33.11% 1.71TCr
Average -0.46%+3.82%+14.79%+126.06% 4TCr
Weighted average by Cap. -0.30%+2.78%+19.67%+132.00%

Financials

2024 2025
Net sales 24Cr 7.7TCr 22Cr 20Cr 18Cr 34Cr 2.25TCr 35Cr 240.49Cr 95Cr 1.2TCr 90Cr 88Cr 3.82TCr 27Cr 8.71TCr 24Cr 23Cr 20Cr 39Cr 2.55TCr 40Cr 272.06Cr 107.88Cr 1.36TCr 101.4Cr 99Cr 4.32TCr
Net income -6.78Cr -2.19TCr -6.14Cr -5.68Cr -5.13Cr -9.66Cr -639.23Cr -10Cr -68Cr -27Cr -341.46Cr -25Cr -25Cr -1.08TCr -3.57Cr -1.15TCr -3.24Cr -2.99Cr -2.7Cr -5.09Cr -336.7Cr -5.27Cr -36Cr -14Cr -179.86Cr -13Cr -13Cr -570.93Cr
Net Debt 13Cr 4.28TCr 12Cr 11Cr 10Cr 19Cr 1.25TCr 20Cr 133.67Cr 53Cr 668.63Cr 50Cr 49Cr 2.12TCr 14Cr 4.4TCr 12Cr 11Cr 10Cr 19Cr 1.29TCr 20Cr 137.28Cr 54Cr 686.69Cr 51Cr 50Cr 2.18TCr
Projected Income Statement - Annual - InterCure Ltd.
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
16/26/16 ILA 1,222.00 -3.17% 826
13/26/13 ILA 1,262.00 +0.16% 3,066
12/26/12 ILA 1,260.00 +1.04% 23,973
11/26/11 ILA 1,247.00 +9.67% 39,693
10/26/10 ILA 1,137.00 +4.50% 13,535
  1. Stock Market
  2. Stocks
  3. INCR Stock